ETV1 Antibody

1. Our data indicate that miR-17-5p acts as a tumour suppressor in Triple-negative breast cancer (TNBC)by targeting ETV1, and a low-abundance of miR-17-5p may be involved in the pathogenesis of TNBC. These findings indicate that miR-17-5p may be a therapeutic target for TNBC PMID: 29126392
2. Our results indicate that assessing AP1 and PEA3 transcription factor status might be a good indicator of OAC status. However, we could not detect any associations with disease stage or patient treatment regime. This suggests that the PEA3-AP1 regulatory module more likely contributes more generally to the cancer phenotype. In keeping with this observation, depletion of ETV1 and/or ETV4 causes an OAC cell growth defect PMID: 28859074
3. Structured and disordered regions cooperatively mediate DNA-binding autoinhibition of ETV1, ETV4 and ETV5. PMID: 28161714
4. the prostate cancer-related oncogenic E26 transformation-specific (ETS) transcription factors, ETV1, ETV4, and ETV5, were required for TAZ gene transcription in PC3 prostate cancer cells PMID: 28408625
5. C646 treatment attenuated ETV1 protein expression and inactivated KIT-dependent pathways. Taken together, the present study suggests that CBP/p300 may serve as novel antineoplastic targets and that use of the selective HAT inhibitor C646 is a promising antitumor strategy for Gastrointestinal stromal tumors. PMID: 27633918
6. these data reveal a JMJD2A/ETV1/YAP1 axis that promotes prostate cancer initiation and that may be a suitable target for therapeutic inhibition. PMID: 26731476
7. conclude that ETV1 is specifically expressed in the majority of gastrointestinal stromal tumors, even in some KIT-negative cases PMID: 26243012
8. ETV1 and COP1 are a pair of independent predictors of prognosis for triple-negative breast cancer. PMID: 25884720
9. ETV1 overexpression is associated with prostate cancer aggressiveness. PMID: 25595908
10. Results show that ETV1 was upregulated at a higher rate in Gastrointestinal stromal tumor and was correlated with KIT expression. PMID: 24970355
11. These results illuminate the complex interplay of AR, ETV1, and PTEN pathways in pre-cancerous neoplasia and early tumorigenesis PMID: 25631336
12. YK-4-279 is a potent inhibitor of ETV1 and inhibits both the primary tumor growth and metastasis of fusion positive prostate cancer xenografts. PMID: 25479232
13. mutation of the KIT protein that stabilizes ETV1 is likely to be a key step by which an endogenous brain-cell progenitor may form a germinoma. PMID: 25736805
14. ETV1 expression is a rare event in human melanoma and seems to be rather based on hyperactivation of MAPK signals, by BRAF (V600E) mutation, than on ETV1 gene amplification. PMID: 25073704
15. developed a novel RNA in situ hybridization-based assay for the in situ detection of ETV1, ETV4, and ETV5 in formalin-fixed paraffin-embedded tissues from prostate needle biopsies, prostatectomy, and metastatic PCa specimens using RNA probes PMID: 25203299
16. Elevated levels of either wild-type ETV1 or its truncated derivative, dETV1, which mimics the product of an oncogenic rearrangement in certain tumors, results in increased expression of mRNA for p14ARF, a known activator of p53. PMID: 24157551
17. These results point to a new avenue for pharmacologic ETV1 inhibition and may inform a general means to discover small molecule perturbagens of transcription factor oncoproteins. PMID: 24737027
18. The gastrointestinal stromal tumor-specific transcription factor ETV1 may have no prognostic potential, whereas its downstream gene KCTD10 is associated with a favorable prognosis. PMID: 23977394
19. ETV1 expression is significantly correlated with Snail expression in human gastric tumor samples. In summary, we present data that ETV1 promotes Snail expression to induce EMT-like metastatic progression in gastric cancer. PMID: 24100634
20. Non-sigma 14-3-3 proteins synergized with ETV1 to activate transcription. PMID: 23774214
21. High ETV1 expression is associated with prostate cancer. PMID: 23076342
22. Proprioceptive sensory neurons innervating hypaxial and axial muscles depend critically on Etv1 for survival. PMID: 23522042
23. Our collective results identify a regulatory pathway involving ETV1, ATR, and TERT that is preferentially important for proliferation of diverse p53- cancer cells PMID: 23284306
24. confirmed the association of an ETV1 expression signature with aggressive disease and poorer outcome in patient data PMID: 23512661
25. Reviews evidence for a role of ETV1, 4 and 5 as oncoproteins and describe modes of their action. PMID: 22425584
26. High ER81 expression is associated with breast cancer. PMID: 22901226
27. Data show that MAPKAP kinase 2 overexpression is associated with expression of p38 MAP kinase and ETV1 in gastrointestinal stromal tumors (GIST). PMID: 22351694
28. Pea3 and Erm, but not Er81, play an important role in the progression of esophageal squamous cell carcinoma PMID: 21689625
29. The coordinate expression of Etv1 with POMC cell differentiation and its interaction with the highly cell-restricted Tpit factor indicate that Etv1 participates in a combinatorial code for pituitary cell-specific gene expression. PMID: 21622576
30. High ER81 expression is associated with gastric adenocarcinoma. PMID: 21673681
31. in clinical prostate cancer overexpression of full-length ETV1 is due to genomic rearrangements involving different chromosomes PMID: 21298110
32. the ETS family member ETV1 is highly expressed in the subtypes of interstitial cells of Cajal sensitive to oncogenic KIT mediated transformation, and is required for their development PMID: 20927104
33. Melanoma cell lines, including those with ETV1 amplification, exhibited dependency on ETV1 expression for proliferation and anchorage-independent growth. PMID: 20160028
34. ER81 is acetylated by two coactivators/acetyltransferases, p300 and p300- and CBP-associated factor (P/CAF) . Whereas p300 acetylates two lysine residues (K33 and K116) within the ER81 N-terminal transactivation domain, P/CAF targets only K116. PMID: 12917345
35. attenuation of transforming growth factor-beta signaling by activating Smad7 transcription may proceed not only through TGF-beta receptor-regulated Smad proteins but also an independent pathway involving transcription factor ER81 and TAK1 protein kinase PMID: 12947087
36. transcription factor ER81 is regulated by oncogenic HER2/Neu and ACTR in mammary tumorigenesis PMID: 14747462
37. findings show that the TMPRSS2-ERG fusion is common in prostate cancer and that the related TMPRSS2-ETV1 fusion is very rare PMID: 17390040
38. Expression transitions from androgen-induced to androgen-independent as prostate cancer cells switch from hormone-dependent to hormone-refractory. PMID: 17505060
39. TMPRSS2-ERV1 fusion protein was found in 1/82 prostate neoplasms. PMID: 17632455
40. These results imply that c-Jun plays a pivotal role in the pathway that connects ligand-activated AR to elevated ETV1 expression, leading to enhanced expression of matrix metalloproteinases and prostate cancer cell invasion. PMID: 17634427
41. Studies report a novel fusion partner for ETV1 and highlight the considerable heterogeneity of ETV1 gene rearrangements in human prostate cancer. PMID: 18594527
42. Sox-9, ER81 and VE-cadherin have roles in retinoic acid-mediated trans-differentiation of breast cancer cells PMID: 18628953
43. ETV1 and HER2/Neu synergized to upregulate the endogenous Rcl gene. ETV1 also bound to the Rcl promoter. PMID: 18726892
44. 1% histologic variant of prostate carcinoma or variation morphologies demonstrated ETV! aberrations PMID: 19465903
45. Transcriptional activation of hTERT in breast carcinomas by the Her2-ER81-related pathway. PMID: 19718948
46. Overexpression of ETV1 is associated with tha induction of prostatic intraepithelial neoplasia. PMID: 19789348

Show More

Hide All

HGNC: 3490

OMIM: 600541

KEGG: hsa:2115

STRING: 9606.ENSP00000385551

UniGene: Hs.22634